vs
Side-by-side financial comparison of Allegiant Travel CO (ALGT) and Pediatrix Medical Group, Inc. (MD). Click either name above to swap in a different company.
Allegiant Travel CO is the larger business by last-quarter revenue ($732.4M vs $493.8M, roughly 1.5× Pediatrix Medical Group, Inc.). Pediatrix Medical Group, Inc. runs the higher net margin — 6.8% vs 5.8%, a 1.0% gap on every dollar of revenue. On growth, Allegiant Travel CO posted the faster year-over-year revenue change (4.8% vs -1.7%). Over the past eight quarters, Allegiant Travel CO's revenue compounded faster (11.0% CAGR vs -0.1%).
Allegiant Air, styled as allegiant, is an American low-cost airline headquartered in Las Vegas, Nevada. The airline focuses on serving leisure traffic from small and medium-sized cities which it considers to be underserved, using an ultra low-cost business model with minimal inclusions in fares and a greater number of add-on fees.
Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.
ALGT vs MD — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $732.4M | $493.8M |
| Net Profit | $42.5M | $33.7M |
| Gross Margin | — | — |
| Operating Margin | 11.1% | 9.9% |
| Net Margin | 5.8% | 6.8% |
| Revenue YoY | 4.8% | -1.7% |
| Net Profit YoY | 32.4% | 10.5% |
| EPS (diluted) | $2.30 | $0.40 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $732.4M | — | ||
| Q4 25 | $595.5M | $493.8M | ||
| Q3 25 | $494.1M | $492.9M | ||
| Q2 25 | $617.9M | $468.8M | ||
| Q1 25 | $616.8M | $458.4M | ||
| Q4 24 | $553.6M | $502.4M | ||
| Q3 24 | $489.0M | $511.2M | ||
| Q2 24 | $594.5M | $504.3M |
| Q1 26 | $42.5M | — | ||
| Q4 25 | $31.9M | $33.7M | ||
| Q3 25 | $-43.6M | $71.7M | ||
| Q2 25 | $-65.2M | $39.3M | ||
| Q1 25 | $32.1M | $20.7M | ||
| Q4 24 | $-216.2M | $30.5M | ||
| Q3 24 | $-36.8M | $19.4M | ||
| Q2 24 | $13.7M | $-153.0M |
| Q1 26 | 11.1% | — | ||
| Q4 25 | 11.2% | 9.9% | ||
| Q3 25 | -5.5% | 13.8% | ||
| Q2 25 | -10.9% | 12.8% | ||
| Q1 25 | 10.5% | 7.0% | ||
| Q4 24 | -47.7% | 7.8% | ||
| Q3 24 | -5.4% | 6.6% | ||
| Q2 24 | 5.9% | -31.3% |
| Q1 26 | 5.8% | — | ||
| Q4 25 | 5.4% | 6.8% | ||
| Q3 25 | -8.8% | 14.5% | ||
| Q2 25 | -10.5% | 8.4% | ||
| Q1 25 | 5.2% | 4.5% | ||
| Q4 24 | -39.1% | 6.1% | ||
| Q3 24 | -7.5% | 3.8% | ||
| Q2 24 | 2.3% | -30.3% |
| Q1 26 | $2.30 | — | ||
| Q4 25 | $1.82 | $0.40 | ||
| Q3 25 | $-2.41 | $0.84 | ||
| Q2 25 | $-3.62 | $0.46 | ||
| Q1 25 | $1.73 | $0.24 | ||
| Q4 24 | $-12.12 | $0.37 | ||
| Q3 24 | $-2.05 | $0.23 | ||
| Q2 24 | $0.75 | $-1.84 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $902.1M | $375.2M |
| Total DebtLower is stronger | — | $570.5M |
| Stockholders' EquityBook value | — | $865.9M |
| Total Assets | — | $2.2B |
| Debt / EquityLower = less leverage | — | 0.66× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $902.1M | — | ||
| Q4 25 | $805.7M | $375.2M | ||
| Q3 25 | $956.7M | $340.1M | ||
| Q2 25 | $842.8M | $224.7M | ||
| Q1 25 | $878.6M | $99.0M | ||
| Q4 24 | $781.1M | $229.9M | ||
| Q3 24 | $759.3M | $103.8M | ||
| Q2 24 | $791.9M | $19.4M |
| Q1 26 | — | — | ||
| Q4 25 | $1.7B | $570.5M | ||
| Q3 25 | $1.8B | $577.2M | ||
| Q2 25 | $1.8B | $583.9M | ||
| Q1 25 | $1.7B | $590.5M | ||
| Q4 24 | $1.6B | $597.1M | ||
| Q3 24 | $1.8B | — | ||
| Q2 24 | $1.7B | — |
| Q1 26 | — | — | ||
| Q4 25 | $1.1B | $865.9M | ||
| Q3 25 | $1.0B | $890.7M | ||
| Q2 25 | $1.1B | $833.8M | ||
| Q1 25 | $1.1B | $789.2M | ||
| Q4 24 | $1.1B | $764.9M | ||
| Q3 24 | $1.3B | $732.5M | ||
| Q2 24 | $1.3B | $706.5M |
| Q1 26 | — | — | ||
| Q4 25 | $4.2B | $2.2B | ||
| Q3 25 | $4.4B | $2.2B | ||
| Q2 25 | $4.4B | $2.1B | ||
| Q1 25 | $4.5B | $2.0B | ||
| Q4 24 | $4.4B | $2.2B | ||
| Q3 24 | $4.8B | $2.1B | ||
| Q2 24 | $4.9B | $2.0B |
| Q1 26 | — | — | ||
| Q4 25 | 1.60× | 0.66× | ||
| Q3 25 | 1.76× | 0.65× | ||
| Q2 25 | 1.68× | 0.70× | ||
| Q1 25 | 1.57× | 0.75× | ||
| Q4 24 | 1.48× | 0.78× | ||
| Q3 24 | 1.36× | — | ||
| Q2 24 | 1.30× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $114.1M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | 3.39× |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $112.2M | $114.1M | ||
| Q3 25 | $-6.1M | $137.3M | ||
| Q2 25 | $92.2M | $137.2M | ||
| Q1 25 | $191.4M | $-117.5M | ||
| Q4 24 | $84.4M | $133.0M | ||
| Q3 24 | $17.3M | $91.8M | ||
| Q2 24 | $68.9M | $107.0M |
| Q1 26 | — | — | ||
| Q4 25 | $90.4M | — | ||
| Q3 25 | $-121.7M | — | ||
| Q2 25 | $-10.5M | — | ||
| Q1 25 | $116.9M | — | ||
| Q4 24 | $24.0M | — | ||
| Q3 24 | $-28.7M | — | ||
| Q2 24 | $7.0M | — |
| Q1 26 | — | — | ||
| Q4 25 | 15.2% | — | ||
| Q3 25 | -24.6% | — | ||
| Q2 25 | -1.7% | — | ||
| Q1 25 | 19.0% | — | ||
| Q4 24 | 4.3% | — | ||
| Q3 24 | -5.9% | — | ||
| Q2 24 | 1.2% | — |
| Q1 26 | — | — | ||
| Q4 25 | 3.7% | — | ||
| Q3 25 | 23.4% | — | ||
| Q2 25 | 16.6% | — | ||
| Q1 25 | 12.1% | — | ||
| Q4 24 | 10.9% | — | ||
| Q3 24 | 9.4% | — | ||
| Q2 24 | 10.4% | — |
| Q1 26 | — | — | ||
| Q4 25 | 3.51× | 3.39× | ||
| Q3 25 | — | 1.91× | ||
| Q2 25 | — | 3.49× | ||
| Q1 25 | 5.96× | -5.66× | ||
| Q4 24 | — | 4.36× | ||
| Q3 24 | — | 4.72× | ||
| Q2 24 | 5.03× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ALGT
| Passenger | $671.8M | 92% |
| Third party products | $42.3M | 6% |
| Fixed fee contracts | $18.1M | 2% |
| Resort and other | $175.0K | 0% |
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
